FindMyKOL
Clinical trialNCT04384848CompletedInterventional

The EMPATHY Pilot Study

SponsorNorthwestern UniversityEnrollment94CancerLeukemia, Chronic Myeloid
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The proposed study, may significantly contribute to improve healthcare delivery in patients with Chronic Myeloid Leukemia (CML) treated with modern tyrosine kinase inhibitors (TKIs) in two ways. First, it may provide novel empirical data on the positive effects of systematically monitoring of patient-reported adverse events (AEs) in routine practice for improving symptom management and adherence to therapy. Second, it will inform the development of a large international randomized controlled trial (RCT) to test whether systematic collection of patient-reported AEs, could improve clinical response to TKI therapy.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Italy
  • Policlinico Sant'Orsola Malpighi - Uoc Ematologia - Azienda Ospedaliero-Universitaria Di Bologna

    Bologna, Italy

  • Ospedale "a. Businco" - Struttura Complessa Di Ematologia E Ctmo - Azienda Ospedaliera G. Brotzu

    Cagliari, Italy

  • Milano Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico - Uoc Oncoematologia - Padiglione Marcora

    Milan, Italy

  • Azienda Ospedaliera Universitaria - Università Degli Studi Di Napoli "federico Ii" - Uoc Ematologia

    Naples, Italy

  • Azienda Ospedaliera Universitaria Maggiore Della Carità Di Novara - Scdu Ematologia

    Novara, Italy

  • Ausl Reggio Emilia - Arcispedale S. Maria Nuova, Ircss - Sc Ematologia

    Reggio Emilia, Italy

  • Azienda Ospedaliera Universitaria Policlinico Umberto I - Università Degli Studi "sapienza" - Uoc Ematologia

    Roma, Italy

  • Ospedale Sant'Eugenio

    Roma, Italy

  • the Gimema Foundation (italian Group for Adult Hematologic Diseases)

    Rome, Italy

  • Azienda Ospedaliero-Universitario Città Della Salute E Della Scienza Di Torino - Ospedale S. Giovanni Battista Molinette - Sc Ematologia

    Torino, Italy

  • Ospedale Mauriziano Umberto I - Torino - Scdu Ematologia

    Torino, Italy

  • Asui Di Udine - Presidio Ospedaliero "santa Maria Della Misericordia" - Clinica Ematologica

    Udine, Italy

  • Azienda Ospedaliera Universitario Integrata Di Verona, Policlinico G.B. Rossi - Uoc Ematologia

    Verona, Italy

  • Usl 6 - Ospedale San Bortolo - Vicenza

    Vicenza, Italy

United States
  • Augusta University, Hematology and Oncology

    Augusta, Georgia, United States

  • Northwestern University, Robert H. Lurie Comprehensive Cancer Center Comprehensive Cancer Center (rhlccc)

    Chicago, Illinois, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Nov 2019
Primary completion
10 Jun 2022
Completion
31 Jul 2022
Last update posted
4 Mar 2024
Registered enrollment
94
Registry id
NCT04384848
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.